Skip to main content
. 2015 Feb 1;8(2):1302–1311.

Figure 5.

Figure 5

Western blotting were performed to determine the expression of p-Akt, Akt, COX-2 and ICAM-1 in 786-O cells. The COX-2 specific inhibitors NS-398 and Akt pathway inhibitor were used in RCC cells 786-O.The dose of NOV was keeped in 100 mg/nl. Untreated cells were used as control. The intensities of proteins were quantified by densitometry analysis using Image J software. Bars indicated the means ± SD from 3 independent experiments.NS-398 and Akt pathway inhibitor treated cells p-AKT, COX-2 and ICAM-1 expression were different with Control or cells treated with Akt pathway inhibitor (P < 0.01). Differences between Control and cells treated with Akt pathway inhibitor were not significantly (P > 0.05).